Clinical Trials in Pittsburgh

Showing 8561-8580 of 16,007 trials

Alglucosidase Alfa Pompe Safety Sub-Registry

NCT01710813

To collect uniform and meaningful data on patients with Pompe disease who experience anaphylaxis, severe allergic reactions, and/or signals of severe cutaneous and/or systemic immune complex-mediated reactions following treatment with alglucosidase alfa.

Pompe Disease

Genzyme, a Sanofi Company110 participantsStarted Mar 2015

Phoenix, Arizona, United States • Durham, North Carolina, United States • Hershey, Pennsylvania, United States +15 more locations

TERMINATEDNA< 1 mile

Neuromuscular Electrical Stimulation for Jaw-closing Dystonia

NCT03889704

6 patients with jaw-closing dystonia will be treated with neuromuscular electrical stimulation over 8 weeks. The distance the mouth can be opened voluntarily and the oro-mandibular dystonia questionnaire (OMDQ-25) will be employed to determine whether there is any objective change in jaw opening or evidence of functional improvement.

Muscle Dystonia

Edward Burton2 participantsStarted May 2019

Pittsburgh, Pennsylvania, United States

Alglucosidase Alfa Pompe Safety Sub-Registry

Neuromuscular Electrical Stimulation for Jaw-closing Dystonia

Find Trials by Condition in Pittsburgh

Long-term Effect of Lanthanum Carbonate on Bone

SAR650984, Pomalidomide and Dexamethasone in Combination in RRMM Patients

A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Safety and Efficacy Study of GRT6005 in Patients With Osteoarthritis (OA) Knee Pain

Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee

Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects

Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis

Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase

Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors.

Study to Investigate Safety, Pharmacokinetic (PK), Pharmacodynamic (PD) and Clinical Activity of Trametinib in Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabrafenib in Subjects With Cancers Harboring V600 Mutations

Efficacy and Safety Study of MYOBLOC® Followed by Open-Label Multiple-Treatment With MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects

NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study

Study to Assess the Effect of Rifampicin on Blood Levels and Safety of AZD9291, in Patients With EGFRm+ NSCLC

Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves

A Multicenter, Open-Label Retreatment Study of the Safety and Effectiveness of PN40082 for Lip Augmentation

Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH)

Intercostal Nerve Block With Liposome Bupivacaine in Subjects Undergoing Posterolateral Thoracotomy

Study Assessing the Efficacy and Safety of Intravitreal Injections of DE-122 in Combination With Lucentis® Compared to Lucentis® Monotherapy in Wet Age-related Macular Degeneration Subjects